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REPLY
We have read with great interest the letters by Sacchetti et al. and
Bellone et al. As stated in the introduction of our article, it was also
the impression of all physicians in our institution involved in the
care of patients with pulmonary edema that BiPAP is indeed
helpful in its treatment. However, as is the case in many other
treatment modalities, sometimes the clinical impression does not
hold in the face of rigorous randomized studies. Therefore, we
have tried in the discussion part of our manuscript to suggest a few
mechanisms to explain the failure of BiPAP in our patient
population. What was especially alarming to us was that the results
in the BiPAP arm were worse than our previous experience with
simple medical therapy (without high-dose nitrates). Accordingly,
we decided to discontinue the study prematurely.
Regarding the remarks by Sacchetti et al. and Bellone et al.:
Firstly, it is possible that some of the harmful effect we observed
was due to combination of BiPAP ventilation with morphine
(although it will be very hard from an ethical point of view to deny
patients this small amount of morphine, which is a proven
treatment for pulmonary edema). Secondly, we have chosen
BiPAP rather than CPAP for our study because BiPAP has some
advantage over CPAP by increasing the tidal volume. Also, it was
our subjective impression that patients tolerate BiPAP better than
CPAP. Thirdly, regarding the BiPAP pressures used in our
protocol, it is possible that the moderate pressures we used in the
BiPAP arm were not enough and higher pressures would have
produced a better effect. However, from our experience, it seemed
to us that patients usually do not tolerate higher pressures. Hence,
we started with lower pressures and increased the pressures
gradually. Furthermore, again taking into account that these two
treatment arms were not compared directly, it seems that the
patients in the BiPAP arm of our study faired worse than our
historical controls that underwent exactly the same treatment
without BiPAP. If the assumption of Sacchetti et al. and Bellone
et al. were correct, then we would expect that the results of the
BiPAP arm would be the same as conservative treatment (basically,
if we administered too little BiPAP it should be the same as
administering a lot of oxygen only).
Regarding the pH and PCO2 measurements suggested by
Bellone et al., these were not performed, because the treatment was
administered at the patients’ homes by paramedic units, which are
not equipped for such measurements.
Finally, regarding the early CK peak induced by BiPAP, we are
not aware of any randomized study demonstrating this event.
However, the negative results in our study included not only high
CK but also an increased rate of mechanical ventilation, lower O2
saturation, and increased total events. Furthermore, what we have
observed was that in the BiPAP arm more patients had an increase
in CK into the MI range. In the others we did not observe a CK
increase at all. Therefore, we believe that this cannot be explained
by early CK release, because the patients who did not have an MI
did not have CK release at all.
Since the publication of our study, another randomized study
comparing BiPAP ventilation, with conservative treatment using
oxygen, morphine, furosemide and low-dose nitrates, was pub-
lished (1). In this study, the outcome of patients treated by BiPAP
ventilation was better than in the control arm, although the study
was small (as was our study) and there were significant inequalities
in baseline parameters between the two groups. Therefore, we
believe that the resolution of this important issue will need further,
larger randomized studies.
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